Searched for: in-biosketch:yes
person:rotroj01
Murine lymphocytes lack clearly defined receptors for muscarinic and dopaminergic ligands
Wazer DE; Rotrosen J
[3H]Quinuclidinyl benzilate and [3H]spiperone binding to murine lymphocytes is displaceable but differs from binding to brain receptor sites for these ligands: (1) binding to intact lymphocyte preparations was not saturable; (2) disruption of intact lymphocytes was associated with a marked loss of displaceable ligand binding; (3) drugs differentially displace these ligands in lymphocytes compared to brain. Displaceable binding was increased following incubation of lymphocytes under phospholipid methylating conditions; however, marked effects on cell viability and cell recovery make it difficult to interpret these binding changes. If dopaminergic and cholinergic receptors do exist on lymphocytes, their binding characteristics are profoundly different from comparable cns receptors
PMID: 6151985
ISSN: 0022-3573
CID: 23632
Side effects of scopolamine administration [Letter]
Serby M; Corwin J; Jordan B; Novatt A; Rotrosen J
PMID: 6465355
ISSN: 0002-953x
CID: 23633
TRH test abnormalities in psychiatric disorders
Wolkin A; Peselow ED; Smith M; Lautin A; Kahn I; Rotrosen J
Blunted responses to thyrotropin-releasing hormone (TRH) stimulation have been found consistently in depressed patients, and have been reported in other affective disorders as well. In a smaller number of schizophrenic subjects, TRH tests have generally been normal. Thus, it has been suggested that this test may have diagnostic utility in distinguishing schizophrenia from affective disorders. In the present study the TRH test was performed upon a sample of 51 subjects that included 17 schizophrenics in order to further study the diagnostic or symptom specificity of this endocrine test. Abnormal TRH tests were present in both schizophrenic and affectively disturbed patients. There were no correlations with ratings of depression or other aspects of psychopathology. Factors which may have previously obscured abnormal TRH tests in schizophrenia are discussed
PMID: 6235258
ISSN: 0165-0327
CID: 23634
REGIONAL GLUCOSE-METABOLISM IN CHRONIC-SCHIZOPHRENIA [Meeting Abstract]
Brodie, JD; Wolkin, A; Wolfe, AP; Jaeger, J; Fowler, J; Rotrosen, J; Cancro, R
ISI:A1984ACT4500057
ISSN: 0167-8760
CID: 30978
Patterns of metabolic activity in the treatment of schizophrenia
Brodie JD; Christman DR; Corona JF; Fowler JS; Gomez-Mont F; Jaeger J; Micheels PA; Rotrosen J; Russell JA; Volkow ND; et al.
Six patients with chronic schizophrenia were studied with positron emission tomography (PET) before and after neuroleptic treatment, using fluorine-18-labeled fluorodeoxyglucose. After treatment, the mean whole-slice glucose metabolic rate at the level of the basal ganglia showed a 25% increase. However, patterns of frontal hypometabolism observed with the schizophrenic patients were not altered by medication. Pattern analysis using the fast Fourier transform was applied to a set of 422 images from a mixed group of normal, depressed, and schizophrenic subjects. Reconstruction of the images with low-frequency coefficients was excellent, reducing considerably the number of variables needed to characterize each image. Hierarchical cluster analysis categorized the transformed images according to anatomical level and subject group (patient versus control). The results suggest the utility of this procedure for the classification and characterization of metabolic PET images from psychiatric patients
PMID: 6611117
ISSN: 0364-5134
CID: 23635
CSF somatostatin in Alzheimer's disease
Serby M; Richardson SB; Twente S; Siekierski J; Corwin J; Rotrosen J
Studies have previously demonstrated low somatostatin levels in autopsy cortical tissue from Alzheimer's disease (AD) patients and low somatostatin levels in CSF obtained from subjects with dementia. We evaluated levels of this peptide in 21 non-depressed subjects, 10 with AD, 2 with Parkinson's disease (PD), and 9 with other neurological conditions. The AD patients had significantly lower mean CSF somatostatin than the 'other' neurological patients (14.6 +/- 1.5 S.E.M. versus 26.7 +/- 3.2 pg/ml, p less than 0.005). A demented PD subject had a level in the range of the AD group, while the non-demented PD patient had a value above this range. Thus, all 11 patients with AD or PD dementia, analogous disorders, had levels below 21.8 mg/ml, while 7 of the 10 remaining patients had values above 21.8 pg/ml. Age did not explain this finding
PMID: 6151123
ISSN: 0197-4580
CID: 23636
Cholecystokinin octapeptide in dementia
Serby M; Angrist B; Corwin J; Funari D; Sudilovsky A; Siekierski J; Peselow E; Rotrosen J
PMID: 6089253
ISSN: 0048-5764
CID: 23637
Norepinephrine stimulation of phospholipid methylation in rat cortical synaptosomes: fact or artifact?
Wazer DE; Mandio Cordasco D; Segarnick DJ; Lippa AS; Meyerson LR; Benson D; Rotrosen J
Synaptosomes from rat cerebral cortex incubated with 3H-S-adenosyl-L-methionine (3H-SAM) displayed an increase in chloroform- extractable tritium when norepinephrine was added to the reaction mixture. The products of this mixture were maximally generated from intact synaptosomes, only partially inhibited by propranolol, and not enhanced by exogenous phospholipids. Thin layer chromatographic analysis of these chloroform extracts in three solvent systems yielded large norepinephrine- stimulated peaks of radioactivity that did not consistently co-chromatograph with authentic methylated phospholipid standards: phosphatidylmonomethylethanolamine (PME), phosphatidyldimethylethanolamine (PDE), and phosphatidylcholine (PC). Further, attempts to identify these peaks of radioactivity using as standards several putative methylated products of varied chemical classes, failed to elucidate likely candidates. It appears that while norepinephrine markedly stimulates the amount of tritium extracted into the chloroform phase, careful and positive structural elucidation of formed products is required before it can be concluded that these are indeed methylated phospholipids
PMID: 6855456
ISSN: 0024-3205
CID: 23638
Differential effects of tricyclic antidepressants on mean arterial pressure in a hypertensive patient [Case Report]
Adler L; Angrist B; Lautin A; Rotrosen J
PMID: 6841662
ISSN: 0271-0749
CID: 23639
Plasma cortisol values after dexamethasone in depressed inpatients
Peselow ED; Serby M; Wolkin A; Deutsch SI; Fricchione G; Rotrosen JP
PMID: 6833525
ISSN: 0271-0749
CID: 23572